When comparing patients who initiated treatment with exenatide (n=14,076, median follow-up: 969 days), to those starting dulaglutide (n=54,787, median follow-up: 948 days) or liraglutide (n=25,562, median follow-up: 1,007 days), no differences were found in the hazard of composite treatment for diabetic macular edema (DME) and/or proliferative DR: exenatide vs
Semaglutide and blood sugar levels Semaglutide directly improves blood sugar control in several ways
By weeks four to eight, most patients report better control over their appetite and find it easier to manage portion sizes, contributing to healthier eating habits
In fact, semaglutide is 94% similar to the GLP-1 that our body produces